Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

  • This share is currently suspended. It was suspended at a price of 0.89
  • There is currently no data for RBGP

Progressive publishes new research

19 Jul 2022 11:26

RNS Number : 9800S
RBG Holdings PLC
19 July 2022
 

Diversified revenue stream … and high margin

RBG is a unique provider and consolidator of high-margin professional services businesses. Strong growth in FY21 and solid trading performance reported in July provides clear evidence that RBG's strategy and commercial approach are delivering. The acquisition of Memery Crystal has added significant scale and breadth to RBG Legal Services (RBGLS), and we expect further selective M&A. Given RBG's better business mix and high returns from contentious work, we see good support for margins. In our view, the current discount to peers is unjust given forecast growth, both organic and through bolt-ons. In addition, we believe the significant upside potential from contingent work and litigation finance, both in-house and third party (LionFish), is not reflected in the share price.

 

 

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

Business Services

Oil & Gas

15 analysts

with average

20 years

Financials

Property

experience of

Healthcare

Retail

 

Industrials

Technology

30+

 

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

For further information please contact:

 

Keith Hodgskiss

+44 (0) 20 7781 5315

khodgskiss@progressive-research.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRARLMMTMTTBBIT
Date   Source Headline
26th Jul 20234:13 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSSale of LionFish Litigation Finance Limited
27th Jun 20237:00 amRNSDirectorate Change
22nd Jun 202311:11 amRNSResult of AGM & Directorate Change
23rd May 20239:07 amRNSNotice of AGM and Dividend
17th May 20233:28 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSResults for the year ended 31 Dec 2022
18th Apr 20237:00 amRNSNotice of Investor Presentation
3rd Mar 202312:44 pmRNSCorrection: Board Changes and Notice of Results
3rd Mar 202312:18 pmRNSBoard Changes and Notice of Results
31st Jan 20237:00 amRNSBoard Changes & Pre-Close Trading Update
3rd Jan 20237:00 amRNSDirectorate Changes
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn
5th Dec 20229:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSTrading & Dividend Update
13th Sep 20227:00 amRNSUnaudited Interim Results
15th Aug 20227:00 amRNSInvestor Presentation
19th Jul 202211:26 amRNSProgressive publishes new research
18th Jul 20227:00 amRNSPre-Close Trading Update
23rd Jun 202212:03 pmRNSResult of AGM
7th Jun 20225:20 pmRNSLimited Employee Share Sale to Satisfy Demand
30th May 20224:55 pmRNSAnnual Report and Accounts and Notice of AGM
1st Apr 20229:33 amRNSCorrection: Results for year ended 31 Dec 2021
1st Apr 20227:01 amRNSAudited results - year ended 31 December 2021
1st Apr 20227:00 amRNSExecutive Incentive Plan
30th Mar 20221:29 pmRNSRevised Notice of Results & Investor Presentation
25th Mar 20222:09 pmRNSRevised Notice of Results
15th Feb 20227:00 amRNS£20 million litigation investment arrangement
27th Jan 20227:00 amRNSPre-Close Trading & Dividend Update
21st Jan 20227:00 amRNSInvestor Presentation
11th Jan 20227:00 amRNSPurchase of Shares by Directors of Convex
2nd Dec 20217:00 amRNSPurchase of Shares by Directors of Convex
29th Sep 20217:00 amRNSPurchase of Shares by Directors of Convex
15th Sep 20217:00 amRNSUnaudited Interim Results
13th Sep 20218:00 amRNSPurchase of Shares by Directors of Convex
2nd Sep 20217:00 amRNSIntegration Update
16th Jul 20217:00 amRNSPre-Close Trading & Dividend Update
5th Jul 20218:03 amRNSPurchase of Shares by Directors of Convex
17th Jun 20212:39 pmRNSBoard Changes
17th Jun 20212:33 pmRNSResult of AGM
28th May 20215:18 pmRNSCompletion of acquisition
25th May 20213:56 pmRNSNotice of AGM and Shareholder Q&A
11th May 20216:09 pmRNSAnnual Report and Accounts and AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.